Kallyope Stock
Kallyope is a healthcare company focusing on biotechnology business.
About Kallyope Stock
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the gut informs our brains about our well-being, metabolism, and nutritional state. The gut-brain axis—the communication highway between our gut and our brain—offers an unprecedented opportunity to access and influence brain centers involved in fundamental human processes. An understanding of the biology mediated by the gut and gut-brain circuits will change the way we think about food, nutrition, and human physiology
Investors
Illumina
Funding History
| December 2015 | $44.0M |
|---|---|
| February 2018 | $66.0M |
Management
CEO
Nancy Thornberry
Founder
Tom Maniatis
Founder
Charles Zuker
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Kallyope or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
